Life Science Company News

Reset
Results 121 - 140 out of 500 displayed.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Cue Biopharma, Inc.

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Coherus BioSciences, Inc.

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Werewolf Therapeutics, Inc.

Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Medicenna Therapeutics Corp.

Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Regeneron Pharmaceuticals Inc.

Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Cullinan Therapeutics, Inc.

Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Ultimovacs ASA

Global COVID-19 Memorial Will Honor Pandemic Frontline & Essential Workers

Read more ››
By: GlobeNewswire - 24 Apr 2024

BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeti

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  BioXcel Therapeutics, Inc.

Invitation to the presentation of ALK’s first quarter results on Friday 3 May 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024

TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  TScan Therapeutics, Inc.

BrightInsight Recognized Among Newsweek’s World’s Best Digital Health Companies 2024 List

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  BrightInsight, Inc.

Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Basilea Pharmaceutica International Ltd

Virbac : Public release of Virbac Annual Report at 31 December 2023 (ESEF format)

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Virbac SA

SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  SpringWorks Therapeutics Inc.

Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Amarin Corporation plc

Boston Scientific Announces Results for First Quarter 2024

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024
Related companies:  Axonics Modulation Technologies®, Inc. | Boston Scientific Corporation

Registration for Association of Bioscience Financial Officers 2024 National Conference in May in Boston Nearing Full Capacity

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024

RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024

REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2024
Related companies:  REGENXBIO Inc.
Results 121 - 140 out of 500 displayed.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »